{"id":"NCT05372653","sponsor":"Otsuka Pharmaceutical Co., Ltd.","briefTitle":"A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitis","officialTitle":"A Phase 3, Multicenter, Open-label, Uncontrolled Trial to Evaluate the Efficacy and Safety of OPA-15406 Ointment in Infants Younger Than 2 Years of Age With Atopic Dermatitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2022-05-23","primaryCompletion":"2022-12-29","completion":"2023-11-29","firstPosted":"2022-05-13","resultsPosted":"2025-03-30","lastUpdate":"2025-03-30"},"enrollment":41,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Atopic Dermatitis (AD)"],"interventions":[{"type":"DRUG","name":"OPA-15406","otherNames":["difamilast"]}],"arms":[{"label":"OPA-15406","type":"EXPERIMENTAL"}],"summary":"To investigate the efficacy of 0.3% OPA-15406 ointment when administered twice daily for 4 weeks in infants younger than 2 years of age with Atopic Dermatitis","primaryOutcome":{"measure":"Success Rate in IGA (Percentage of Subjects With an IGA Score of 0 or 1 With Improvement by at Least 2 Grades)","timeFrame":"Week 4","effectByArm":[{"arm":"0.3% OPA-15406","deltaMin":56.1,"sd":null}],"pValues":[]},"eligibility":{"minAge":"3 Months","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":null},"locations":{"siteCount":1,"countries":["Japan"]},"refs":{"pmids":["39075274"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":41},"commonTop":["Nasopharyngitis","Gastroenteritis","Dermatitis contact","COVID-19","Dermatitis diaper"]}}